Regulatory and Commercial Research & Consulting    

Jouhou Koukai Services LLC and its businesses provide information and intelligence on the Japanese pharmaceutical market in the fields of drug and medical device approval, regulatory and pharmaceutical affairs, and market data.

Company of the week:
Kitasato Institute Research Center for Biologicals

Kitasato Institute Research Center for Biologicals in Saitama

 

Regulatory and Commercial Headlines

JKS News: XML  RSS feed

●August 26, 2010: Flu pandemic in Japan (update 12) - preparedness of drugs: Four major pharma makers announced their readiness to supply anti-flu drugs for the 2010/11 season: Chugai Seiyaku KK Chugai Seiyaku headoffice in Mitsui Honkan BldgChugai Seiyaku headoffice in Mitsui Honkan Bldg - Tamiflu for about 12 millions patients; GlaxoSmithKline Japan KK GSK headoffice in TokyoGSK headoffice in Tokyo - Relenza for about 6 millions patients; Shionogi Seiyaku KK Shionogi Seiyaku headoffice in OsakaShionogi Seiyaku headoffice in Osaka Rapiacta (Peramivir) for about 1 million patients; and Daiichi-Sankyo KK Daiichi-Sankyo brandmarkDaiichi-Sankyo brandmark Inavir for about 1 million patients ... Anti-flu products in JAD Databases | Epidemiology consulting and data

●August 20, 2010: Generics in Japan update: Two of the last major Indian pharma manufacturers not yet presented in Japan - Dr. Reddy's Laboratories Ltd. and Sun Pharmaceutical Industries Ltd. announced plans to enter the expanding market for generics; ● recent Medipeer survey revealed that prescribing physicians most trusted major drug makers (40.5%), domestic generics makers (21.5%), mid-size pharmas (11.3%), against foreign generic manufacturers (1%) ... Generics in JAD Databases | Generics report preview

●August 4, 2010: Cancer update: After the expiration in Japan of Gemzar patent of Nippon Eli Lilly KK Eli Lilly HQ in KobeEli Lilly HQ in Kobe 3 generic versions of gemcitabine were launched in July as on August 3rd, a Health Ministry Advisory panel agreed to expand the indications so to include also ovarian cancer ... Related report


... all headline news

DOCUMENTS STORE

PDF Document Japan Master Files - view

PDF Document Accredited Foreign Manufacturers preview

PDF Document Japan Orphan Drugs
preview

PDF Document Japan Pricing & Reimbursement preview

PDF Document Japanese Generics and API
preview

PDF Document Stigmatized Markets: ED
preview

PDF Document Stigmatized Markets: Depression preview

PDF Document Stigmatized Markets: Genital Herpes preview

PDF Document Stigmatized Markets: Metabolic Syndrome preview

PDF Document Unapproved Medicinal Products (drug lag) preview

PDF Document Vaccines and Sera (vaccine gap) preview

READING ROOM

New free resources

MEDIA & NEWS

EContent Magazine: Jouhou Koukai Adds to Database

 

Jouhou Koukai Services LLC
The main information services and B2B e-commerce site of the Jouhou Koukai Services LLC - the leading provider of pharmaceutical development, regulatory and business intelligence information on the Japanese pharma and medical device market. The site contains the only English-language database of medicinal products approved in Japan from 1999 until present (Japan Approvals Database, JAD), free information resources and the online JKS Document Store (e-documents and e-books). Linked are the sites of the key businesses of JKS - primary market research (www.licenscape.com) and ehealth (www.ehealth-japan.com).